vs
Acadia Healthcare Company, Inc.（ACHC）とADVANCED DRAINAGE SYSTEMS, INC.（WMS）の財務データ比較。上の社名をクリックして会社を切り替えられます
Acadia Healthcare Company, Inc.の直近四半期売上が大きい（$829.0M vs $693.4M、ADVANCED DRAINAGE SYSTEMS, INC.の約1.2倍）。ADVANCED DRAINAGE SYSTEMS, INC.の純利益率が高く（13.5% vs 0.5%、差は13.0%）。Acadia Healthcare Company, Inc.の前年同期比売上増加率が高い（7.5% vs 0.4%）。過去8四半期でADVANCED DRAINAGE SYSTEMS, INC.の売上複合成長率が高い（3.0% vs 2.0%）
アカディア・ヘルスケアはアメリカ合衆国に本拠を置く営利目的の行動医療サービス提供企業です。現在アメリカ本土とプエルトリコにわたり225カ所以上の医療施設を運営し、広範な行動ヘルスケアネットワークを構築して、専門的なサービスを提供しています。
アドバンスド・ドレネージ・システムズ（略称ADS）は米国の企業で、ポリプロピレン・ポリエチレン製パイプ、プラスチック製浸出場システム、浄化槽と付属部品、雨水調整施設、PVC製排水構造物、継手、水ろ過・分離装置の設計・製造・販売を行い、米国最大の高密度ポリエチレンパイプメーカーです。本社はオハイオ州ヒリアードに所在します。
ACHC vs WMS — 直接比較
損益計算書 — Q1 FY2026 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $829.0M | $693.4M |
| 純利益 | $4.5M | $93.6M |
| 粗利率 | — | 37.4% |
| 営業利益率 | — | 19.7% |
| 純利益率 | 0.5% | 13.5% |
| 売上前年比 | 7.5% | 0.4% |
| 純利益前年比 | -50.8% | 15.3% |
| EPS（希薄化後） | $0.05 | $1.19 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $693.4M | ||
| Q3 25 | $851.6M | $850.4M | ||
| Q2 25 | $869.2M | $829.9M | ||
| Q1 25 | $770.5M | $615.8M | ||
| Q4 24 | $774.2M | $690.5M | ||
| Q3 24 | $815.6M | $782.6M | ||
| Q2 24 | $796.0M | $815.3M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $93.6M | ||
| Q3 25 | $36.2M | $156.0M | ||
| Q2 25 | $30.1M | $143.9M | ||
| Q1 25 | $8.4M | $77.2M | ||
| Q4 24 | $32.6M | $81.2M | ||
| Q3 24 | $68.1M | $130.4M | ||
| Q2 24 | $78.5M | $161.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 37.4% | ||
| Q3 25 | — | 40.0% | ||
| Q2 25 | — | 39.8% | ||
| Q1 25 | — | 36.7% | ||
| Q4 24 | — | 35.0% | ||
| Q3 24 | — | 37.6% | ||
| Q2 24 | — | 40.8% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 19.7% | ||
| Q3 25 | 4.7% | 26.3% | ||
| Q2 25 | 5.8% | 24.8% | ||
| Q1 25 | 1.7% | 19.0% | ||
| Q4 24 | 4.9% | 18.4% | ||
| Q3 24 | 12.1% | 23.9% | ||
| Q2 24 | 13.4% | 27.7% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 13.5% | ||
| Q3 25 | 4.3% | 18.3% | ||
| Q2 25 | 3.5% | 17.3% | ||
| Q1 25 | 1.1% | 12.5% | ||
| Q4 24 | 4.2% | 11.8% | ||
| Q3 24 | 8.4% | 16.7% | ||
| Q2 24 | 9.9% | 19.8% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.19 | ||
| Q3 25 | $0.40 | $1.99 | ||
| Q2 25 | $0.33 | $1.84 | ||
| Q1 25 | $0.09 | $0.99 | ||
| Q4 24 | $0.36 | $1.04 | ||
| Q3 24 | $0.74 | $1.67 | ||
| Q2 24 | $0.85 | $2.06 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $158.5M | $1.0B |
| 総負債低いほど良い | $2.5B | — |
| 株主資本純資産 | $2.0B | $1.9B |
| 総資産 | $5.5B | $4.1B |
| 負債/資本比率低いほどレバレッジが低い | 1.29× | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $1.0B | ||
| Q3 25 | $118.7M | $812.9M | ||
| Q2 25 | $131.4M | $638.3M | ||
| Q1 25 | $91.2M | $463.3M | ||
| Q4 24 | $76.3M | $488.9M | ||
| Q3 24 | $82.1M | $613.0M | ||
| Q2 24 | $77.2M | $541.6M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | $1.3B | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $1.9B | ||
| Q3 25 | $3.1B | $1.8B | ||
| Q2 25 | $3.1B | $1.7B | ||
| Q1 25 | $3.0B | $1.5B | ||
| Q4 24 | $3.1B | $1.5B | ||
| Q3 24 | $3.0B | $1.4B | ||
| Q2 24 | $3.0B | $1.3B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $4.1B | ||
| Q3 25 | $6.4B | $4.1B | ||
| Q2 25 | $6.3B | $3.9B | ||
| Q1 25 | $6.1B | $3.7B | ||
| Q4 24 | $6.0B | $3.6B | ||
| Q3 24 | $5.9B | $3.5B | ||
| Q2 24 | $5.7B | $3.4B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | 0.83× | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $61.5M | $269.3M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $183.6M |
| FCFマージンFCF / 売上 | — | 26.5% |
| 設備投資強度設備投資 / 売上 | — | 12.4% |
| キャッシュ転換率営業CF / 純利益 | 13.78× | 2.88× |
| 直近12ヶ月FCF直近4四半期 | — | $577.1M |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $269.3M | ||
| Q3 25 | $73.2M | $234.9M | ||
| Q2 25 | $133.5M | $275.0M | ||
| Q1 25 | $11.5M | $41.2M | ||
| Q4 24 | $116.7M | $189.9M | ||
| Q3 24 | $163.1M | $166.9M | ||
| Q2 24 | $171.1M | $183.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $183.6M | ||
| Q3 25 | $-63.0M | $176.4M | ||
| Q2 25 | $-34.2M | $222.4M | ||
| Q1 25 | $-163.2M | $-5.3M | ||
| Q4 24 | $-86.8M | $135.7M | ||
| Q3 24 | $-27.1M | $112.4M | ||
| Q2 24 | $16.9M | $125.7M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 26.5% | ||
| Q3 25 | -7.4% | 20.7% | ||
| Q2 25 | -3.9% | 26.8% | ||
| Q1 25 | -21.2% | -0.9% | ||
| Q4 24 | -11.2% | 19.7% | ||
| Q3 24 | -3.3% | 14.4% | ||
| Q2 24 | 2.1% | 15.4% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 12.4% | ||
| Q3 25 | 16.0% | 6.9% | ||
| Q2 25 | 19.3% | 6.3% | ||
| Q1 25 | 22.7% | 7.6% | ||
| Q4 24 | 26.3% | 7.9% | ||
| Q3 24 | 23.3% | 7.0% | ||
| Q2 24 | 19.4% | 7.1% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 2.88× | ||
| Q3 25 | 2.02× | 1.51× | ||
| Q2 25 | 4.43× | 1.91× | ||
| Q1 25 | 1.37× | 0.53× | ||
| Q4 24 | 3.58× | 2.34× | ||
| Q3 24 | 2.39× | 1.28× | ||
| Q2 24 | 2.18× | 1.14× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
WMS
| Reportable Segment Aggregation Before Other Operating Segment | $557.3M | 80% |
| Other | $85.5M | 12% |
| Pipe | $35.5M | 5% |
| Allied Products And Other | $15.0M | 2% |
